title: Erythema induratum of Bazin which occurred after tumor necrosis factor antagonist therapy.
authors.affiliation: Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
authors.forename: Natsuki
authors.initials: N
authors.lastname: Baba
authors.affiliation: Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
authors.forename: Wataru
authors.initials: W
authors.lastname: Takashima
authors.affiliation: Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tokuriki
authors.affiliation: Department of Respiratory Medicine, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
authors.forename: Shingo
authors.initials: S
authors.lastname: Ameshima
authors.affiliation: Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
authors.forename: Minoru
authors.initials: M
authors.lastname: Hasegawa
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D000068582:Certolizumab Pegol / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004891:Erythema Induratum / Q000139:chemically induced*; D004977:Ethambutol; D005260:Female; D006801:Humans; D007866:Leg; D016133:Polymerase Chain Reaction; D014388:Tuberculosis, Lymph Node / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D004977:Ethambutol; D000068582:Certolizumab Pegol